Survival Outcomes with Regorafenib and/or Trifluridine/Tipiracil Sequencing to Rechallenge with Third-Line Regimens in Metastatic Colorectal Cancer: A Multicenter Retrospective Real-World Subgroup Comparison from the ReTrITA Study.
Signorelli C, Calegari MA, Anghelone A, Passardi A, Frassineti GL, Bittoni A, Lucchetti J, Angotti L, Di Giacomo E, Zurlo IV, Morelli C, Dell'Aquila E, Artemi A, Gemma D, Corsi DC, Emiliani A, Ribelli M, Mazzuca F, Arrivi G, Zoratto F, Chilelli MG, Schirripa M, Morandi MG, Santamaria F, Dettori M, Cosimati A, Saltarelli R, Minelli A, Lucci-Cordisco E, Basso M.
Signorelli C, et al. Among authors: arrivi g.
Curr Oncol. 2024 Dec 4;31(12):7793-7808. doi: 10.3390/curroncol31120574.
Curr Oncol. 2024.
PMID: 39727697
Free PMC article.